IRIS
CIABATTINI, ANNALISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.931
NA - Nord America 4.823
AS - Asia 2.418
SA - Sud America 439
AF - Africa 44
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.662
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.743
RU - Federazione Russa 1.234
IT - Italia 904
CN - Cina 832
SG - Singapore 784
GB - Regno Unito 685
IE - Irlanda 634
BR - Brasile 374
SE - Svezia 317
DE - Germania 311
FI - Finlandia 232
UA - Ucraina 213
HK - Hong Kong 201
VN - Vietnam 188
FR - Francia 186
KR - Corea 165
IN - India 75
CA - Canada 43
ES - Italia 42
PL - Polonia 35
BD - Bangladesh 32
NL - Olanda 30
MX - Messico 23
AR - Argentina 22
BE - Belgio 21
AT - Austria 19
JP - Giappone 19
IQ - Iraq 17
UZ - Uzbekistan 16
CZ - Repubblica Ceca 14
ZA - Sudafrica 14
IR - Iran 13
EC - Ecuador 11
CI - Costa d'Avorio 10
LT - Lituania 10
TR - Turchia 10
CH - Svizzera 9
GR - Grecia 9
IL - Israele 9
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
ID - Indonesia 7
PK - Pakistan 6
SA - Arabia Saudita 6
AZ - Azerbaigian 5
BO - Bolivia 5
CL - Cile 5
EG - Egitto 5
PE - Perù 5
PT - Portogallo 5
CO - Colombia 4
DO - Repubblica Dominicana 4
JO - Giordania 4
PY - Paraguay 4
RO - Romania 4
TH - Thailandia 4
AL - Albania 3
AU - Australia 3
KE - Kenya 3
MA - Marocco 3
NO - Norvegia 3
PH - Filippine 3
TN - Tunisia 3
BG - Bulgaria 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
JM - Giamaica 2
KZ - Kazakistan 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
BB - Barbados 1
BH - Bahrain 1
GD - Grenada 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.662
Salva come PNG Salva come JPEG
Città #
Dallas 709
Dublin 633
Southend 553
Fairfield 481
Singapore 459
Ashburn 398
Chandler 332
Moscow 330
Santa Clara 277
Siena 264
Beijing 231
Woodbridge 219
Hong Kong 197
Jacksonville 174
Hefei 170
Ann Arbor 161
Seattle 160
Seoul 158
Cambridge 155
Houston 151
Munich 144
Wilmington 140
Helsinki 112
Los Angeles 100
Princeton 97
New York 93
Milan 88
Rome 69
Dong Ket 68
Lappeenranta 64
Florence 58
Nanjing 58
São Paulo 37
Ho Chi Minh City 34
The Dalles 34
Shanghai 33
San Mateo 32
Hanoi 31
Buffalo 28
Boardman 27
San Diego 27
London 26
Menlo Park 22
Turku 22
Brussels 21
Council Bluffs 21
Düsseldorf 21
Nuremberg 21
Shenyang 21
Bengaluru 20
Denver 20
Redondo Beach 19
Tokyo 19
Chicago 18
Lancaster 18
Warsaw 18
Montreal 16
Málaga 16
Columbus 15
Lauterbourg 15
Nanchang 15
Belo Horizonte 14
Dearborn 14
Messina 14
Phoenix 14
San Francisco 14
Toronto 14
Washington 14
Atlanta 13
Fremont 13
Tashkent 13
Frankfurt am Main 12
Guangzhou 12
Hebei 12
Portsmouth 12
Kunming 11
Orem 11
Redwood City 11
Abidjan 10
Changsha 10
Chennai 10
Piscataway 10
Rio de Janeiro 10
Amsterdam 9
Brno 9
Brooklyn 9
Curitiba 9
Poggibonsi 9
Tianjin 9
Boston 8
Dhaka 8
Jiaxing 8
Jinan 8
Mumbai 8
Stockholm 8
Campinas 7
Naples 7
Norwalk 7
Bacoli 6
Brescia 6
Totale 8.373
Salva come PNG Salva come JPEG
Nome #
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 322
Vaginal immunization to elicit primary T-cell activation and dissemination 306
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study 279
Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation 278
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 273
Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice 261
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 258
Adoptive transfer of transgenic T cells to study mucosal adjuvants 252
Ebola vaccine R&D: Filling the knowledge gaps 245
Role of the microbiota in the modulation of vaccine immune responses 245
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 241
Characterization of the antigen-specific CD4+ T cell response induced by prime-boost strategies with CAF01 and CpG adjuvants administered by the intranasal and subcutaneous routes 231
Bacillus spores for vaccine delivery 229
In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii 223
Vaccination in the elderly: The challenge of immune changes with aging 218
Modulation of Primary Immune Response by Different Vaccine Adjuvants 214
Optimized protocol for the detection of multifunctional epitope-specific CD4+ T cells combining MHC-II tetramer and intracellular cytokine staining technologies 213
High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot 208
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 191
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 190
Transcriptomics of the vaccine immune response: Priming with adjuvant modulates recall innate responses after boosting 188
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 186
Long-term anti-bacterial immunity against systemic infection by Salmonella enterica serovar typhimurium elicited by a GMMA-based vaccine 186
Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4(+) and CD8(+) T cells in the genital and intestinal tracts 184
Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii 184
Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA. 181
CD4+ T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines 178
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 174
Immunization with the conjugate vaccine Vi-CRM(197) against Salmonella Typhi induces Vi-specific mucosal and systemic immune responses in mice 172
Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine 172
Antibody response and protection from challenge in mice immunized with recombinant Streptococcus gordonii expressing fragment C of tetanus toxin 168
Prime-boost strategies in mucosal immunization affect local IgA production and the type of th response 166
Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice 165
Comparison of Immune Responses Elicited by BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 Vaccines. 162
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients 161
In vivo primary activation of CD4+ and CD8+ T-cells following mucosal vaccination 161
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population 160
Oral priming of mice by recombinant spores of Bacillus subtilis 158
CTA1-DD has an Adjuvant Effect Once Expressed on the Surface of the Gram-Positive Bacterium Streptococcus gordonii 158
Primary T-cell response to mucosal vaccination 157
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity? 156
Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge 156
Induzione primaria di linfociti T CD4 nel tessuto linfoide associato al naso (NALT) in seguito ad immunizzazione con Streptococcus gordonii 155
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability 154
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration 153
Computational Analysis of Multiparametric Flow Cytometric Data to Dissect B Cell Subsets in Vaccine Studies 152
From bivariate to multivariate analysis of cytometric data: overview of computational methods and their application in vaccination studies 151
Surface display of recombinant proteins on Bacillus subtilis spores 150
Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria 150
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination 149
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 148
Recombinant gram-positive bacteria for intranasal immunization: characterization of the murine nasal-associated lymphoid tissue and study of local T-cell priming 148
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine 147
Nasal and vaginal routes of immunization for CD4+ and CD8+ T-cell priming 146
Spike-Specific memory B cell response in hematopoietic cell transplantation recipients following multiple mRNA-1273 vaccinations: a longitudinal observational study 145
Correction to: High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot 132
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine 131
Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patients 128
Oral priming of mice using recombinant spores of Bacillus subtilis 122
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein 121
Primary activation of CD4+ and CD8+ T cells following mucosal vaccination with recombinant bacteria 120
The slower antibody response in myelofibrosis patients after two doses of MRNA sars-COV-2 vaccine calls for a third dose 116
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant 113
Vaccinazione anti SARSCov2 in una coorte di pazienti sottoposti a trapianto di cuore o di polmone: risposta umorale a dosi booster 113
Expression of immunomodulating molecules on the surface of the vaccine vector Streptococcus gordonii 113
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses 112
Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study 112
Using IFN-gamma release assay to confirm tuberculin skin test improves the screening of latent tuberculosis infection in Italian healthcare workers 106
null 102
Third Sars-CoV-2 vaccine dose: B cell and antibody responses following heterologous and homologous vaccination strategies. 101
Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GP 97
Profiling the B cell immune response elicited by vaccination against the respiratory virus SARS-CoV-2 97
Successivi booster vaccinali contro SARS-CoV-2: risposta umorale in pazienti sottoposti a trapianto di cuore o di polmone 96
Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a machine learning approach 94
Persistence of spike-specific memory B cells and antibodies nine months after two doses of BNT162b2 mRNA vaccine. 92
Longitudinal profiling of spike-specific antibody and B cell responses following mRNA-1273 SARS-CoV-2 vaccination in hematopoietic cell transplantation recipients 79
Totale 12.855
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.040
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021775 0 0 0 0 0 100 41 134 92 195 96 117
2021/2022837 64 127 43 59 29 14 44 28 44 80 115 190
2022/20231.223 77 142 173 136 103 220 41 104 88 31 81 27
2023/20241.202 33 34 100 79 55 307 367 43 24 65 25 70
2024/20252.606 80 97 271 138 313 166 144 161 269 111 244 612
2025/20263.820 459 796 593 763 1.079 130 0 0 0 0 0 0
Totale 12.855